We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Cheap in Croatia

27 Jun 2006 By Robert Cyran

The US generic drug maker fought off several competitors to buy the Eastern European firm. Contested auctions are normally bad news for bidders. But Pliva s expertise in making generic biotech drugs may mean Barr got a bargain.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)